Plasmonic magnetic nanoparticles-enabled universal enrichment, photothermal lysis, and duplex CRISPR detection of bacteria in urine samples
Biosensors and Bioelectronics · 2026-06 · 302 · 118518
DOI: 10.1016/j.bios.2026.118518 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026-06. Verfasst von Zhijie Tu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Center of AMMS, Beijing, 100850, PR China. Hauptthemen laut MEDLINE: Enterococcus faecalis, Escherichia coli, Biosensing Techniques, Urinary Tract Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Nova Program.
Abstract (Originalsprache)
Urinary tract infections (UTIs), exacerbated by antibiotic resistance and evolving pathogen diversity, demand rapid and sensitive diagnostics. This study introduces an integrated platform combining magnetic enrichment, photothermal lysis, and CRISPR-based detection (ME-CRISPR) for simultaneous identification of Escherichia coli (E. coli) and Enterococcus faecalis (E. faecalis) in UTIs. We engineered plasmonic magnetic nanoparticles functionalized with 4-mercaptophenylboronic acid for broad-spectrum bacterial capture within 10 min. Subsequent near-infrared laser irradiation leveraged localized surface plasmon resonance to lyse captured bacteria in situ. The released nucleic acids were directly analyzed in a single-step duplex RPA-CRISPR/Cas12a-Cas13a assay. This 40-min workflow achieved a limit of detection of 10 CFU/mL for both pathogens. Validation with 90 clinical samples (39 E. coli, 26 E. faecalis, and 25 negative controls) demonstrated 100% sensitivity and specificity, matching qPCR performance while significantly reducing turnaround time. The platform overcomes limitations of centrifugation and Gram-class-dependent lysis, offering a rapid and ultrasensitive point-of-care testing tool to curb antibiotic misuse.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioinformatics Center of AMMS, Beijing, 100850, PR China.
- Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, PR China.
- South China University of Technology, Guangzhou, 510641, PR China.
- Department of Clinical Laboratory, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210000, PR China.
- Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210000, PR China. Electronic address: apan1987@s…
- Bioinformatics Center of AMMS, Beijing, 100850, PR China; State Key Laboratory of Kidney Diseases, Beijing, 100853, PR China. Electronic address: sqwang@bmi.ac.cn.
Förderung
- National Natural Science Foundation of China
- Beijing Nova Program
Zitieren
APA
Tu, Z., Wang, Y., Qian, X., Chen, J., Li, L., Wang, T., Chen, H., Wei, H., Yang, P., Pan, J., Wang, S., & Rong, Z. (2026). Plasmonic magnetic nanoparticles-enabled universal enrichment, photothermal lysis, and duplex CRISPR detection of bacteria in urine samples. Biosensors and Bioelectronics, 302, 118518. https://doi.org/10.1016/j.bios.2026.118518
Vancouver
Tu Z, Wang Y, Qian X, Chen J, Li L, Wang T, et al. Plasmonic magnetic nanoparticles-enabled universal enrichment, photothermal lysis, and duplex CRISPR detection of bacteria in urine samples. Biosensors and Bioelectronics. 2026;302:118518. doi:10.1016/j.bios.2026.118518
BibTeX
@article{Tu2026,
author = {Tu, Zhijie and Wang, Yunxiang and Qian, Xiang and Chen, Jinli and Li, Lingyun and Wang, Tianci and Chen, Hong and Wei, Hongjuan and Yang, Ping and Pan, Junping and Wang, Shengqi and Rong, Zhen},
title = {Plasmonic magnetic nanoparticles-enabled universal enrichment, photothermal lysis, and duplex CRISPR detection of bacteria in urine samples},
journal = {Biosensors and Bioelectronics},
year = {2026},
volume = {302},
pages = {118518},
doi = {10.1016/j.bios.2026.118518}
}
EUVIMED